Sign In
Buy AHAC
$10.96
+0 (+0%)
At Close: May 27, 2022
Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp.
04:05pm, Thursday, 26'th Aug 2021
DURHAM, N.C., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today
Alpha Healthcare Acquisition Corp. Sets August 24, 2021, for Special Shareholder Meeting to Vote on Humacyte Business Combination
04:53pm, Wednesday, 04'th Aug 2021
NEW YORK and DURHAM, N.C., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC) (“AHAC”), a special purpose acquisition company, today announced that it has filed a
EXCLUSIVE: Humacyte, Alpha Healthcare CEOs Talk SPAC Deal, Technology, Trials On 'SPACs Attack'
03:35pm, Tuesday, 25'th May 2021
Humacyte is set to go public via the special purpose acquisition company Alpha Healthcare Acquisition Corp (NASDAQ: AHAC) in a deal that values the company at around $800 million. Humacyte found
2 SPAC Stocks That Could Be 10-Baggers
06:05am, Sunday, 14'th Mar 2021
They could even deliver greater gains than just a 10-times return.
DURHAM, N.C., March 05, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, toda
Humacyte: Disrupting The Organ Transplant Industry
10:10am, Friday, 26'th Feb 2021
Humacyte has a platform technology allowing for the mass production of human organs and blood vessels within a laboratory. Its products are superior as they can be stored for over a year, pose little
Why Humacyte Is Going Public Via SPAC
05:50pm, Wednesday, 17'th Feb 2021
Feb.17 -- Dr. Laura Niklason, chief executive officer and founder of Humacyte, discusses the biotech company's decision to go public through a merger with Alpha Healthcare Acquisition Corp., a speci
Regenerative Tissue Developer Humacyte Going Public Via SPAC
01:49pm, Wednesday, 17'th Feb 2021
Humacyte is a leader in regenerative medicine, growing human tissue in the lab that can be transplanted into any patient.
